Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
 Your new post is loading...
Your new post is loading...
Scoop.it!
The early success of a new class of cancer drugs, revealed in test results released here over the last several days, has raised hope among the world’s top cancer specialists that they may be on the verge of an important milestone in the fight against the disease.
No comment yet.
Sign up to comment
Scoop.it!
One of the biggest problems in treating HIV patients is the amount of daily individual medications it takes to keep the virus at bay. In a new study, scientists at the Stanford University School of Medicine have engineered a new approach to tailored gene therapy that they say makes key cells of the immune system resistant to attack from the HIV virus, which may eventually lead to the removal of life-long dependencies on drugs for patients living with HIV.
Scoop.it!
Whether it’s in hospitals, restaurant kitchens or our homes, harmful bacteria such as E.coli are a constant concern. Making matters worse is the fact that such bacteria are increasingly developing a resistance to antibiotics. This has led to a number of research projects, which have utilized things such as blue light, cold plasma and ozone to kill germs. One of the latest non-antibiotic bacteria-slayers is a hydrogel developed by IBM Research and the Institute of Bioengineering and Nanotechnology in Singapore.
Scoop.it!
Over a year-long period ending in August, NEJM published 73 articles on original studies of new drugs, encompassing drugs approved by the FDA since 2000 and experimental drugs, according to a review by The Washington Post.
Of those articles, 60 were funded by a pharmaceutical company, 50 were co-written by drug company employees and 37 had a lead author, typically an academic, who had previously accepted outside compensation from the sponsoring drug company in the form of consultant pay, grants or speaker fees.
|
Scoop.it!
A new drug designed to prevent the early stages of Alzheimer’s disease could enter clinical trials in a few years’ time, according to scientists.
Christina Mediate's comment,
February 24, 2013 5:56 PM
Being able to stop the formation of senile plaques makes this drug look promising. Those plaques are what cause the damage to the brain cells and start the initial memory loss. I'm anxious to see how it works on humans though. Right now it's only safe on the mice. But this is a very crucial step towards a possible new treatment or cure for the disease.
Scoop.it!
A beer a day might not keep the doctor away but hops, one of the basic ingredients in beer brewing, could be good for you.
In a development that could lead to better drug treatments for diabetes and cancer, University of Washington research associate professor of chemistry, Werner Kaminsky, has determined the exact structure of humulones and their derivatives – the acids in hops that give beer its distinctive bitter taste.
Scoop.it!
Seattle’s Presage Biosciences has developed a device which introduces small amounts of different chemotherapy drugs into a patient's tumor. The tumor is inspected after removal and the most effective of the drugs are used for post-surgical chemotherapy, resulting in more efficient, personalized cancer treatments. The new device is awaiting FDA approval, but is currently being used to facilitate development of new chemotherapy drugs.
|
